vs
爱齐科技（ALGN）与泰尼特医疗（HCSG）财务数据对比。点击上方公司名可切换其他公司
爱齐科技的季度营收约是泰尼特医疗的2.2倍（$1.0B vs $466.7M）。泰尼特医疗同比增速更快（6.6% vs 5.3%）。爱齐科技自由现金流更多（$187.3M vs $16.0M）。过去两年泰尼特医疗的营收复合增速更高（5.0% vs 2.5%）
爱齐科技是一家全球知名医疗设备企业，主营设计、生产及销售隐适美透明矫治器、iTero口内扫描仪及配套服务，客户覆盖正畸医师、全科牙医，面向修复、美容牙科领域，业务分为透明矫治器、扫描仪及服务两大板块，可满足青少年等不同群体的正畸需求
泰尼特医疗集团是一家总部位于达拉斯的美国上市营利性跨国医疗服务企业，旗下通过品牌、子公司、合资企业及合作项目（包括联合外科合作伙伴国际USPI），运营着65家医院与超450家医疗机构，此外还经营康尼弗医疗解决方案，为医疗系统及其他客户提供医疗配套服务支持。
ALGN vs HCSG — 直观对比
营收规模更大
ALGN
是对方的2.2倍
$466.7M
营收增速更快
HCSG
高出1.3%
5.3%
自由现金流更多
ALGN
多$171.3M
$16.0M
两年增速更快
HCSG
近两年复合增速
2.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $466.7M |
| 净利润 | $135.8M | — |
| 毛利率 | 65.3% | 15.4% |
| 营业利润率 | 14.8% | 6.1% |
| 净利率 | 13.0% | — |
| 营收同比 | 5.3% | 6.6% |
| 净利润同比 | 30.8% | — |
| 每股收益（稀释后） | $1.88 | $0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALGNHCSG
| Q4 25 | $1.0B | $466.7M | ||
| Q3 25 | $995.7M | $464.3M | ||
| Q2 25 | $1.0B | $458.5M | ||
| Q1 25 | $979.3M | $447.7M | ||
| Q4 24 | $995.2M | $437.8M | ||
| Q3 24 | $977.9M | $428.1M | ||
| Q2 24 | $1.0B | $426.3M | ||
| Q1 24 | $997.4M | $423.4M |
净利润ALGNHCSG
| Q4 25 | $135.8M | — | ||
| Q3 25 | $56.8M | $43.0M | ||
| Q2 25 | $124.6M | $-32.4M | ||
| Q1 25 | $93.2M | $17.2M | ||
| Q4 24 | $103.8M | — | ||
| Q3 24 | $116.0M | $14.0M | ||
| Q2 24 | $96.6M | $-1.8M | ||
| Q1 24 | $105.0M | $15.3M |
毛利率ALGNHCSG
| Q4 25 | 65.3% | 15.4% | ||
| Q3 25 | 64.2% | 20.8% | ||
| Q2 25 | 69.9% | 0.6% | ||
| Q1 25 | 69.5% | 15.2% | ||
| Q4 24 | 70.0% | 13.4% | ||
| Q3 24 | 69.7% | 14.8% | ||
| Q2 24 | 70.3% | 9.7% | ||
| Q1 24 | 70.0% | 15.2% |
营业利润率ALGNHCSG
| Q4 25 | 14.8% | 6.1% | ||
| Q3 25 | 9.7% | 12.3% | ||
| Q2 25 | 16.1% | -9.1% | ||
| Q1 25 | 13.4% | 5.3% | ||
| Q4 24 | 14.5% | 3.4% | ||
| Q3 24 | 16.6% | 4.4% | ||
| Q2 24 | 14.3% | -0.5% | ||
| Q1 24 | 15.5% | 5.0% |
净利率ALGNHCSG
| Q4 25 | 13.0% | — | ||
| Q3 25 | 5.7% | 9.3% | ||
| Q2 25 | 12.3% | -7.1% | ||
| Q1 25 | 9.5% | 3.8% | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 11.9% | 3.3% | ||
| Q2 24 | 9.4% | -0.4% | ||
| Q1 24 | 10.5% | 3.6% |
每股收益（稀释后）ALGNHCSG
| Q4 25 | $1.88 | $0.43 | ||
| Q3 25 | $0.78 | $0.59 | ||
| Q2 25 | $1.72 | $-0.44 | ||
| Q1 25 | $1.27 | $0.23 | ||
| Q4 24 | $1.40 | $0.15 | ||
| Q3 24 | $1.55 | $0.19 | ||
| Q2 24 | $1.28 | $-0.02 | ||
| Q1 24 | $1.39 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $168.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.0B | $510.2M |
| 总资产 | $6.2B | $794.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALGNHCSG
| Q4 25 | $1.1B | $168.0M | ||
| Q3 25 | $1.0B | $177.5M | ||
| Q2 25 | $901.2M | $134.5M | ||
| Q1 25 | $873.0M | $114.8M | ||
| Q4 24 | $1.0B | $107.3M | ||
| Q3 24 | $1.0B | $103.8M | ||
| Q2 24 | $761.4M | $105.6M | ||
| Q1 24 | $865.8M | $104.9M |
股东权益ALGNHCSG
| Q4 25 | $4.0B | $510.2M | ||
| Q3 25 | $4.0B | $496.0M | ||
| Q2 25 | $3.9B | $477.0M | ||
| Q1 25 | $3.8B | $514.2M | ||
| Q4 24 | $3.9B | $499.9M | ||
| Q3 24 | $3.9B | $488.7M | ||
| Q2 24 | $3.8B | $471.4M | ||
| Q1 24 | $3.8B | $474.6M |
总资产ALGNHCSG
| Q4 25 | $6.2B | $794.3M | ||
| Q3 25 | $6.2B | $804.3M | ||
| Q2 25 | $6.2B | $802.2M | ||
| Q1 25 | $6.1B | $823.0M | ||
| Q4 24 | $6.2B | $802.8M | ||
| Q3 24 | $6.4B | $805.8M | ||
| Q2 24 | $6.2B | $799.7M | ||
| Q1 24 | $6.2B | $803.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $223.2M | $17.4M |
| 自由现金流经营现金流 - 资本支出 | $187.3M | $16.0M |
| 自由现金流率自由现金流/营收 | 17.9% | 3.4% |
| 资本支出强度资本支出/营收 | 3.4% | 0.3% |
| 现金转化率经营现金流/净利润 | 1.64× | — |
| 过去12个月自由现金流最近4个季度 | $490.8M | $139.2M |
8季度趋势，按日历期对齐
经营现金流ALGNHCSG
| Q4 25 | $223.2M | $17.4M | ||
| Q3 25 | $188.7M | $71.3M | ||
| Q2 25 | $128.7M | $28.8M | ||
| Q1 25 | $52.7M | $27.5M | ||
| Q4 24 | $286.1M | $36.2M | ||
| Q3 24 | $263.7M | $4.3M | ||
| Q2 24 | $159.8M | $16.3M | ||
| Q1 24 | $28.7M | $-26.0M |
自由现金流ALGNHCSG
| Q4 25 | $187.3M | $16.0M | ||
| Q3 25 | $169.0M | $70.0M | ||
| Q2 25 | $107.2M | $27.4M | ||
| Q1 25 | $27.4M | $25.8M | ||
| Q4 24 | $263.1M | $34.8M | ||
| Q3 24 | $233.9M | $2.9M | ||
| Q2 24 | $106.4M | $15.0M | ||
| Q1 24 | $19.3M | $-28.2M |
自由现金流率ALGNHCSG
| Q4 25 | 17.9% | 3.4% | ||
| Q3 25 | 17.0% | 15.1% | ||
| Q2 25 | 10.6% | 6.0% | ||
| Q1 25 | 2.8% | 5.8% | ||
| Q4 24 | 26.4% | 7.9% | ||
| Q3 24 | 23.9% | 0.7% | ||
| Q2 24 | 10.3% | 3.5% | ||
| Q1 24 | 1.9% | -6.7% |
资本支出强度ALGNHCSG
| Q4 25 | 3.4% | 0.3% | ||
| Q3 25 | 2.0% | 0.3% | ||
| Q2 25 | 2.1% | 0.3% | ||
| Q1 25 | 2.6% | 0.4% | ||
| Q4 24 | 2.3% | 0.3% | ||
| Q3 24 | 3.0% | 0.3% | ||
| Q2 24 | 5.2% | 0.3% | ||
| Q1 24 | 0.9% | 0.5% |
现金转化率ALGNHCSG
| Q4 25 | 1.64× | — | ||
| Q3 25 | 3.33× | 1.66× | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 0.57× | 1.60× | ||
| Q4 24 | 2.76× | — | ||
| Q3 24 | 2.27× | 0.31× | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 0.27× | -1.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
